Terms: = Skin cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Prognosis
7 results:
1. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
; ; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
[TBL] [Abstract] [Full Text] [Related]
2. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
[TBL] [Abstract] [Full Text] [Related]
3. Tuberous Sclerosis Complex: Genetic counselling and perinatal follow-up.
Touraine R; Hauet Q; Harzallah I; Baruteau AE
Arch Pediatr; 2022 Dec; 29(5S):5S3-5S7. PubMed ID: 36585068
[TBL] [Abstract] [Full Text] [Related]
4. Phenotypic distinctions between mosaic forms of tuberous sclerosis complex.
Treichel AM; Hamieh L; Nathan NR; Tyburczy ME; Wang JA; Oyerinde O; Raiciulescu S; Julien-Williams P; Jones AM; Gopalakrishnan V; Moss J; Kwiatkowski DJ; Darling TN
Genet Med; 2019 Nov; 21(11):2594-2604. PubMed ID: 31114024
[TBL] [Abstract] [Full Text] [Related]
5. Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases.
Sciacca P; Giacchi V; Mattia C; Greco F; Smilari P; Betta P; Distefano G
BMC Cardiovasc Disord; 2014 May; 14():66. PubMed ID: 24884933
[TBL] [Abstract] [Full Text] [Related]
6. Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of tsc2.
Lopez-Rivera E; Jayaraman P; Parikh F; Davies MA; Ekmekcioglu S; Izadmehr S; Milton DR; Chipuk JE; Grimm EA; Estrada Y; Aguirre-Ghiso J; Sikora AG
Cancer Res; 2014 Feb; 74(4):1067-78. PubMed ID: 24398473
[TBL] [Abstract] [Full Text] [Related]
7. Lymphangioleiomyomatosis and tuberous sclerosis.
Hancock E; Tomkins S; Sampson J; Osborne J
Respir Med; 2002 Jan; 96(1):7-13. PubMed ID: 11863212
[TBL] [Abstract] [Full Text] [Related]
